Company / Operating Cash Flow per Share
Caribou Biosciences, Inc. Operating Cash Flow per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.20
FY2025
5-year range
-$3.30 / -$0.54
FY2021-FY2025
Trend
-13.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 5 years, ranging from $-3.30 in FY2021 to $-0.54 in FY2022.
Based on SEC 10-K filings.
-1.20 in FY2025.
Improved from $-1.49 to $-1.20 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 13.9% year-over-year.
- Peak operating cash flow per share was recorded in FY2022.
- Lowest operating cash flow per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.99 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.20 | -13.9% |
| FY2024 | -$1.05 | +29.2% |
| FY2023 | -$1.49 | -176.2% |
| FY2022 | -$0.54 | +83.6% |
| FY2021 | -$3.30 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026